Patents by Inventor John Ernest Sims

John Ernest Sims has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies That Inhibit TSLP Activity
    Publication number: 20130225490
    Abstract: The invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.
    Type: Application
    Filed: May 6, 2013
    Publication date: August 29, 2013
    Applicant: IMMUNEX CORPORATION
    Inventors: John Ernest Sims, Stewart D. Lyman, Hilary J. McKenna, Allison P. Armstrong
  • Antibodies to SIGIRR
    Patent number: 7767793
    Abstract: DNA encoding SIGIRR polypeptides and methods for using the encoded polypeptides are disclosed.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: August 3, 2010
    Inventor: John Ernest Sims
  • SIGIRR DNA and Polypeptides
    Publication number: 20090111973
    Abstract: DNA encoding SIGIRR polypeptides and methods for using the encoded polypeptides are disclosed.
    Type: Application
    Filed: October 30, 2007
    Publication date: April 30, 2009
    Applicant: IMMUNEX CORPORATION
    Inventor: John Ernest Sims
  • SIGIRR DNA and polypeptides
    Patent number: 7446171
    Abstract: DNA encoding SIGIRR polypeptides and methods for using the encoded polypeptides are disclosed.
    Type: Grant
    Filed: March 7, 2006
    Date of Patent: November 4, 2008
    Assignee: Immunex Corporation
    Inventor: John Ernest Sims
  • Nucleic acid molecules encoding SIGIRR polypeptides
    Patent number: 7037675
    Abstract: The invention is directed to purified and isolated SIGIRR polypeptides and fragments thereof, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and uses thereof.
    Type: Grant
    Filed: June 22, 2000
    Date of Patent: May 2, 2006
    Assignee: Immunex Corporation
    Inventor: John Ernest Sims
  • Il-1 genotype in early kidney allograft rejection
    Publication number: 20040229228
    Abstract: There are disclosed methods for identifying patients at increased risk for early rejection of a kidney allograft, as well as primer sets and kits useful in such methods. Also disclosed are methods of treating allograft recipients using immunosuppressive therapy, based on their risk for early kidney graft rejection.
    Type: Application
    Filed: July 24, 2003
    Publication date: November 18, 2004
    Applicants: Northwestern University, Amgen, Inc.
    Inventors: John Ernest Sims, Dixon B. Kaufman